Accueil > Documentation > OGM & GMO > Des lords génétiquement modifiés ?!

Des lords génétiquement modifiés ?!

jeudi 17 décembre 2015 - Rédaction SNP

Pour avoir pondu un tel rapport !!! plus sûrement quel regret de ne pas avoir réussi en mars 2012 a intéresser la communauté scientifique française tétanisée par le lobbying politico-écolo, à cette démarche pour nos chers charançons .......

 House of Lords Recognises the Potential of GM Insects in Seminal Report, Oxitec in the news

OXFORD, UK, 17th December 2015

The House of Lords Science and Technology Select Committee published today the findings of their four month investigation into GM insects with strong recognition of their potential to improve lives worldwide by controlling harmful pests that spread disease and damage food crops.

The Report, Genetically Modified Insects, recognises that GM insects have considerable potential to help address a range of challenges. “The sheer disease burden means that all avenues should be explored, and the positive outcome from Oxitec’s dengue fever field trials should be capitalized on. This potential must be explored ; it would be a mistake not to pursue GM insect technologies for a range of potential applications.” The Committee also calls for more funding support “to maintain the UK’s position as a world-leader in GM insect technology,” and for improvements in regulation “to ensure that the regulatory regime is fit-for-purpose”.

Chair of the Committee Lord Selborne said, “GM insect technologies have the potential … to save countless lives worldwide.” “Our report concludes that the UK Government has a moral duty to test the potential of this technology, for the long-term benefit of those countries where diseases like dengue and malaria are indiscriminate killers.”

Oxitec is the only GM insect company in the world, and develops solutions to control insect pests that spread disease and damage crops in a way that is safe, sustainable and environmentally friendly.

The self-limiting insect control developed by Oxitec has been trialled against dengue fever-carrying mosquitoes in several countries, successfully reducing target insect populations by over 90% – an unprecedented level of control. This approach has now been approved by the National Biosafety Committee in Brazil (CTNBio) for use throughout the country and the city of Piracicaba is leading the way with the world’s first municipal partnership releasing Oxitec mosquitoes. Oxitec’s Medfly has also been approved for outdoor trials in Brazil and its diamondback moth is currently being trialled in the US.

The environmental profile of this mating-based approach is of particular benefit because Oxitec mosquitoes only control the target pest, leaving other species unaffected. In addition, the approach is self-limiting ; the released GM insects and their offspring die, which means that the pest population can be precisely targeted and controlled, and the released GM insects do not persist in the environment. Oxitec’s insects also carry a fluorescent marker that aids monitoring through simple identification.

Oxitec CEO Hadyn Parry said, “We are delighted that the House of Lords, following a highly rigorous process, has come out with such a strong statement of support. Our focus has always been on helping to stop mosquito borne diseases, but like us, the Committee also recognises the considerable potential in agriculture. We urge the UK Government to act on the direction of this report and help us bring this approach to countries labouring under the threat of diseases such as Dengue, Chikungunya and Zika Virus.”

About Oxitec

Oxitec is a pioneer in using genetic engineering to control insect pests that spread disease and damage crops, and was founded in 2002 as a spinout from Oxford University (UK). Oxitec is a subsidiary of Intrexon Corporation (NYSE : XON), which aims to apply biology to help solve some of the world’s biggest problems.

Diseases spread by the Aedes aegypti mosquito

  Dengue Fever infects an estimated 390 million people every year with about 40% of the world’s population perpetually at risk.

 Chikungunya swept into Central America and the Caribbean in 2013 with an epidemic spiking to over a million cases within only a year.

 Zika Virus is rapidly spreading into new countries and has caused a state of emergency in Brazil where it has been linked to a sudden increase in birth defects in children (microcephaly).

 Yellow Fever remains a major health threat. There are an estimated 200,000 cases of yellow fever, causing 30,000 deaths, worldwide each year, with 90% occurring in Africa.

About the report

The Genetically Modified Insects report by the House of Lords Science and Technology Select Committee is available online

House of Lords Recognises the Potential of GM Insects



Derniers articles

18 juillet, par Rédaction SNP

Protocole d’intervention sur palmiers infectés- RECTIFICATIF

Rectificatif du 18-07-2019
Protocole d’intervention sanitaire sur les palmiers infectés par le charançon rouge du palmier (Rhynchophorus ferrugineus)
- texte initial : > Ce protocole (...)

17 juillet, par Rédaction SNP

Actualité juridique du développement durable

La législation française " ambitionne" de favoriser le développement des produits du bio contrôle. Mais au-delà des intentions quid de l’efficacité et la rapidité dans les procédures. 14 projets pour 2 M€ c’est notoirement (...)

15 juillet, par Rédaction SNP

La Sénatrice Jacky DEROMEDI (suite)

La sénatrice nous adresse copie de la lettre reçue du ministre Didier Guillaume. Il faut d’emblée nous féliciter de l’intérêt porté à cette question à ce niveau de responsabilité.
On aurait aimé que le texte lui-même soit (...)


Edito de mai 2019

23 juin, par Rédaction SNP

Chers amis et passionnés du palmier,
Le nouvel arrêté de lutte contre le charançon rouge n’est toujours pas sorti. Il faut dire que le ministère conscient des difficultés énormes consécutives du retrait de solutions phytosanitaires particulièrement insecticides, à la lourdeur des procédures de nouveaux agréments de solutions bio, a fait feu de tout bois pour publier des dérogations articles 53 ( autorisations de mise sur le marché d’une (...)